Canton Strategic Holdings, Inc.
Close on Oct 19, 2026
- Market cap
- $366.50M
- P/E (TTM)
- –
- Dividend yield
- –
About Canton Strategic
Finance Services, SIC 6199
Canton Strategic Holdings, Inc. is an enterprise focused on digital asset treasury operations and clinical-stage biotechnology development. The company conducts business through two main operational segments: digital asset treasury management and biotechnology research. Within its digital asset segment, the organization holds Canton Coin, operates as a network validator, and supports the Canton Network to foster institutional blockchain adoption and the digitization of financial markets. In its biotechnology business, it develops drug candidates targeted at inflammatory and immunologic conditions characterized by significant unmet medical need. Because its pharmaceutical pipeline remains in clinical development and its digital asset activities center on network participation and balance sheet management, the filing identifies no commercial customers.
Regarding physical presence and operational scale, the provided filing contains no disclosures concerning the number of operating facilities, employee counts, or international countries of operation. The company maintains its principal executive offices in Red Bank, New Jersey.
Summary of the business section of Canton Strategic's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Canton Strategic Holdings, Inc.
- Headquarters
- New York, NY
- Address
- 1460 Broadway 10036
- Phone
- (212) 210-6006
- Website
- cantonstrategic.com
- Employees
- 12, Dec 31, 2025
- Industry
- Finance Services
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Rosenberg Rich Baker Berman P.A, Somerset, New Jersey
Stock & identifiers
- Ticker
- CNTN
- Exchange
- Nasdaq
- IPO date
- Jan 13, 2022
- Shares outstanding
- 80M, Aug 13, 2026
- Public float
- $6.40M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- Stock splits
- 1-for-15 reverse, May 28, 2024; 1-for-25 reverse, Feb 23, 2024; 1-for-25 reverse, Nov 21, 2023
- SEC CIK
- 1861657
- CUSIP
- 432705309
- ISIN
- US4327053090
- LEI
- 52990040X8C60JYNXZ70
- EIN
- 84-2642541
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Vincent S. LoPriore | Executive Chairman, Director | 732,424 |
| Sanam Parikh | COO, Director | 1,770 |
| Sireesh Appajosyula | CEO, Director | 66,771 |
| Randy Milby | CEO, Director | 17,534 |
| Angela Dominy Radkowski | Chief Operating Officer | – |
| Jacob Asbury | Chief Financial Officer | – |
| Mark Paul Wendland | Chief Executive Officer | – |
| Mark Christopher Toomey | President | – |
| Dong Kim | CFO | – |
| Sean Galvin | Director | – |
| Pamela L. Carter | Director | – |
| Rishi Nangalia | Director | – |
| Gary S. Stetz | Director | 134,175 |
| Jill E. Sommers | Director | – |
| William Thomas Wiley Jr. | Director | – |
| Thomas Clay Kahler | Director | – |
| James Gordon Liddy | Director | – |
| Nancy Davis Rickel | Director | – |
| Kelly Anderson | Director | 6,300 |
Employees
Headcount reported in annual reports
“currently employ 12 full-time employees.”
Corporate history
Events identified from SEC filings